secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001213900-26-039943
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed files prospectus supplement for ATM offering of common shares under existing Sales Agreement
--------------------------------------------------------------------------------

- Filed prospectus supplement dated April 3, 2026 for at-the-market equity offering.
- ATM facility is under Sales Agreement with H.C. Wainwright & Co., originally dated April 7, 2022, amended June 27, 2024.
- Shelf registration statement on Form S-3 (File No. 333-294503) declared effective March 30, 2026.
- No specific number of shares or dollar amount disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390026039943/0001213900-26-039943-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390026039943/ea0284989-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-039943

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer